Thrombosis in children with malignancy

被引:38
作者
Bajzar, L
Chan, AK
Massicotte, MP
Mitchell, LG
机构
[1] Pediat Thrombosis Program, Peter Olley Chair Pediat Thrombosis, Edmonton, AB T6G 2N8, Canada
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Dent Pharm Ctr 1 130, Edmonton, AB T6G 2N8, Canada
关键词
antithrombotic therapy; malignancy; thromboembolism;
D O I
10.1097/01.mop.0000193270.09001.ea
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose of review The association between thrombosis and malignancy in adults is well known. Children are now surviving malignancies that previously resulted in mortality. Complications, however, occur including thrombosis that result in mortality and morbidity. This review will explore the association in children and discuss the epidemiology and evidence-based diagnosis and treatment of thrombosis in this cohort. Recent findings Thrombin is an important link between malignancy, metastases, and inflammation. The accurate diagnosis of thrombosis in the upper venous system is directly related to the diagnostic technique used. Antithrombotic treatment is challenging owing to higher risks of bleeding, for example, decreased platelet counts, tiffelitis, large Summary Thrombosis and malignancy are associated in children. Properly designed studies are urgently required to further define the epidemiology of thrombosis in different malignancies and to find the best way to diagnose and treat thrombosis in children.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 63 条
[1]   VENOUS THROMBOEMBOLIC COMPLICATIONS (VTE) IN CHILDREN - FIRST ANALYSES OF THE CANADIAN REGISTRY OF VTE [J].
ANDREW, M ;
DAVID, M ;
ADAMS, M ;
ALI, K ;
ANDERSON, R ;
BARNARD, D ;
BERNSTEIN, M ;
BRISSON, L ;
CAIRNEY, B ;
DESAI, D ;
GRANT, R ;
ISRAELS, S ;
JARDINE, L ;
LUKE, B ;
MASSICOTTE, P ;
SILVA, M .
BLOOD, 1994, 83 (05) :1251-1257
[2]  
BAJZAR L, 1993, J BIOL CHEM, V268, P8608
[3]   Platelets, leukocytes, and coagulation [J].
Bouchard, BA ;
Tracy, PB .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (05) :263-269
[4]   Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin [J].
Crowther, MA ;
Berry, LR ;
Monagle, PT ;
Chan, AKC .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) :178-186
[5]   The prothrombotic state in cancer: pathogenic mechanisms [J].
De Cicco, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (03) :187-196
[6]   Clinically evident venous thromboembolic events in children with brain tumors [J].
Deitcher, SR ;
Gajjar, A ;
Kun, L ;
Heideman, RL .
JOURNAL OF PEDIATRICS, 2004, 145 (06) :848-850
[7]   Cerebral sinovenous thrombosis in children. [J].
deVeber, G ;
Andrew, M ;
Adams, C ;
Bjornson, B ;
Booth, F ;
Buckley, DJ ;
Camfield, CS ;
David, M ;
Humphreys, P ;
Langevin, P ;
MacDonald, EA ;
Gillett, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :417-423
[8]   Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia [J].
Elhasid, R ;
Lanir, N ;
Sharon, R ;
Ben Arush, MW ;
Levin, C ;
Postovsky, S ;
Ben Barak, A ;
Brenner, B .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (05) :367-370
[9]   CEREBROVASCULAR COMPLICATIONS OF L-ASPARAGINASE THERAPY [J].
FEINBERG, WM ;
SWENSON, MR .
NEUROLOGY, 1988, 38 (01) :127-133
[10]   Catheter-related thrombosis in children with cancer [J].
Glaser, DW ;
Medeiros, D ;
Rollins, N ;
Buchanan, GR .
JOURNAL OF PEDIATRICS, 2001, 138 (02) :255-259